Mountain Pacific Investment Advisers Inc. ID grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 397,006 shares of the medical instruments supplier’s stock after acquiring an additional 5,615 shares during the period. DENTSPLY SIRONA comprises about 2.6% of Mountain Pacific Investment Advisers Inc. ID’s investment portfolio, making the stock its 14th biggest position. Mountain Pacific Investment Advisers Inc. ID owned about 0.17% of DENTSPLY SIRONA worth $23,745,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in XRAY. Veritas Asset Management LLP increased its holdings in shares of DENTSPLY SIRONA by 2.6% in the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after purchasing an additional 157,616 shares during the last quarter. Royce & Associates LP increased its holdings in shares of DENTSPLY SIRONA by 23.4% in the second quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock worth $8,212,000 after purchasing an additional 24,000 shares during the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in shares of DENTSPLY SIRONA by 78.7% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock worth $771,000 after purchasing an additional 5,236 shares during the last quarter. Gateway Investment Advisers LLC increased its holdings in shares of DENTSPLY SIRONA by 8.4% in the second quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock worth $1,258,000 after purchasing an additional 1,499 shares during the last quarter. Finally, Delta Lloyd Asset Management N.V. bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth about $15,624,000. Institutional investors and hedge funds own 93.87% of the company’s stock.

Several equities research analysts have recently issued reports on the company. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Friday. Robert W. Baird set a $63.00 price objective on DENTSPLY SIRONA and gave the stock a “buy” rating in a research note on Thursday. Stifel Nicolaus reissued a “buy” rating on shares of DENTSPLY SIRONA in a research note on Thursday. Morgan Stanley reissued an “overweight” rating and set a $69.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. Finally, Cleveland Research cut DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday, October 5th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $65.60.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded down 0.154% during midday trading on Monday, hitting $61.745. 545,262 shares of the stock traded hands. The company’s market cap is $14.17 billion. The company’s 50 day moving average is $58.51 and its 200-day moving average is $61.00. DENTSPLY SIRONA Inc. has a one year low of $52.54 and a one year high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting analysts’ consensus estimates of $0.65. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.76 earnings per share. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-shares-bought-by-mountain-pacific-investment-advisers-inc-id/1649757.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.